Press Releases

Denver, Colorado, May 31, 2024 (GLOBE NEWSWIRE) -- YES Communities, a Denver-based operator of manufactured housing, announced that one of the 2024 winners of the Building Futures Scholarship is Camila Alvarez Salsas, a local Arrupe Jesuit High School student. This unique opportunity allows Camila to earn class credit while participating in a hands-on work-study program at the YES headquarters in Denver and earn $5,000 towards her college education.

"We are thrilled... (continue reading...)

Weekly Report (May 23-30, 2024) Second Tranche of Stellantis 2024 Share Buyback Program

AMSTERDAM, May 31, 2024 - Stellantis N.V. (“Stellantis” or the “Company”) announced today that pursuant to its Second Tranche of the 2024 Share Buyback Program announced on May 23, 2024, covering up to €1 billion to be executed in the open market during the period between May 23, 2024 and August 30, 2024, it has repurchased the following common shares in the period... (continue reading...)

PITTSBURGH, May 31, 2024 /PRNewswire/ -- "I wanted to create an entertaining new board game with a fun marine-theme twist," said an inventor, from Carneys Point, N.J., "so I invented CATCH'EM WHERE THEY SWIM. My game design enables you to learn about sea creatures, while competing to buy and sell to win the game."

The patent-pending invention provides... (continue reading...)

BOSTON--(BUSINESS WIRE)-- HITEC Sensors today announced it received the BAE Systems ‘Partner 2 Win’ Supplier of the Year award. HITEC Sensors was selected from a pool of suppliers that delivered exceptional performance and contributions to supply chain success for BAE Systems’ Electronic Systems sector in 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240531049861/en/

HITEC Sensors received... (continue reading...)

– Late-breaking data from phase 3 KONFIDENT trial of sebetralstat published in NEJM and presented concurrently at the European Academy of Allergy and Clinical Immunology Congress 2024 –

– Interim data from KONFIDENT-S open-label trial show median time to treatment of 9 minutes and median time to beginning of symptom relief for laryngeal attacks 1.3 hours –

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (NASDAQ: ... (continue reading...)